36 related articles for article (PubMed ID: 19448669)
1. C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells.
Klempnauer KH
Oncotarget; 2023 Mar; 14():174-177. PubMed ID: 36913305
[TBL] [Abstract][Full Text] [Related]
2. The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.
Coulibaly A; Haas A; Steinmann S; Jakobs A; Schmidt TJ; Klempnauer KH
PLoS One; 2018; 13(2):e0190934. PubMed ID: 29394256
[TBL] [Abstract][Full Text] [Related]
3. Helenalin Acetate, a Natural Sesquiterpene Lactone with Anti-inflammatory and Anti-cancer Activity, Disrupts the Cooperation of CCAAT Box/Enhancer-binding Protein β (C/EBPβ) and Co-activator p300.
Jakobs A; Steinmann S; Henrich SM; Schmidt TJ; Klempnauer KH
J Biol Chem; 2016 Dec; 291(50):26098-26108. PubMed ID: 27803164
[TBL] [Abstract][Full Text] [Related]
4. Structural insights into interactions of C/EBP transcriptional activators with the Taz2 domain of p300.
Bhaumik P; Davis J; Tropea JE; Cherry S; Johnson PF; Miller M
Acta Crystallogr D Biol Crystallogr; 2014 Jul; 70(Pt 7):1914-21. PubMed ID: 25004968
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea responsiveness in β-thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity.
Pourfarzad F; von Lindern M; Azarkeivan A; Hou J; Kia SK; Esteghamat F; van Ijcken W; Philipsen S; Najmabadi H; Grosveld F
Haematologica; 2013 May; 98(5):696-704. PubMed ID: 23100274
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression: the dark side of myc.
Herkert B; Eilers M
Genes Cancer; 2010 Jun; 1(6):580-6. PubMed ID: 21779459
[TBL] [Abstract][Full Text] [Related]
7. Transcription-based COX-2 inhibition: a therapeutic strategy.
Wu KK
Thromb Haemost; 2006 Oct; 96(4):417-22. PubMed ID: 17003917
[TBL] [Abstract][Full Text] [Related]
8. Multiple mechanisms of growth hormone-regulated gene transcription.
Ceseña TI; Cui TX; Piwien-Pilipuk G; Kaplani J; Calinescu AA; Huo JS; Iñiguez-Lluhí JA; Kwok R; Schwartz J
Mol Genet Metab; 2007 Feb; 90(2):126-33. PubMed ID: 17129742
[TBL] [Abstract][Full Text] [Related]
9. v-Myc inhibits C/EBPbeta activity by preventing C/EBPbeta-induced phosphorylation of the co-activator p300.
Steinmann S; Schulte K; Beck K; Chachra S; Bujnicki T; Klempnauer KH
Oncogene; 2009 Jul; 28(26):2446-55. PubMed ID: 19448669
[TBL] [Abstract][Full Text] [Related]
10. Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation.
Lee SJ; Kim SG
Mol Pharmacol; 2006 Jan; 69(1):385-96. PubMed ID: 16246908
[TBL] [Abstract][Full Text] [Related]
11. Interaction and cooperation of the CCAAT-box enhancer-binding protein β (C/EBPβ) with the homeodomain-interacting protein kinase 2 (Hipk2).
Steinmann S; Coulibaly A; Ohnheiser J; Jakobs A; Klempnauer KH
J Biol Chem; 2013 Aug; 288(31):22257-69. PubMed ID: 23782693
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Myb-responsive enhancer of the chicken C/EBPbeta gene.
Kintscher J; Yamkamon V; Braas D; Klempnauer KH
Oncogene; 2004 Jul; 23(34):5807-14. PubMed ID: 15195136
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
